JP2023539367A5 - - Google Patents
Info
- Publication number
- JP2023539367A5 JP2023539367A5 JP2023514413A JP2023514413A JP2023539367A5 JP 2023539367 A5 JP2023539367 A5 JP 2023539367A5 JP 2023514413 A JP2023514413 A JP 2023514413A JP 2023514413 A JP2023514413 A JP 2023514413A JP 2023539367 A5 JP2023539367 A5 JP 2023539367A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- seq
- nucleic acid
- sequence
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073837P | 2020-09-02 | 2020-09-02 | |
| US63/073,837 | 2020-09-02 | ||
| PCT/US2021/048510 WO2022051294A1 (en) | 2020-09-02 | 2021-08-31 | Codon optimized rep1 genes and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023539367A JP2023539367A (ja) | 2023-09-13 |
| JP2023539367A5 true JP2023539367A5 (enExample) | 2024-09-09 |
Family
ID=80356143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514413A Pending JP2023539367A (ja) | 2020-09-02 | 2021-08-31 | コドン最適化したｒｅｐ１遺伝子およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US11357870B2 (enExample) |
| EP (1) | EP4208182A4 (enExample) |
| JP (1) | JP2023539367A (enExample) |
| KR (1) | KR102888699B1 (enExample) |
| CN (1) | CN116806158A (enExample) |
| AU (1) | AU2021337580B2 (enExample) |
| BR (1) | BR112023003840A2 (enExample) |
| CA (1) | CA3191545A1 (enExample) |
| IL (1) | IL300752A (enExample) |
| WO (1) | WO2022051294A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026030354A2 (en) * | 2024-07-29 | 2026-02-05 | Remedium Bio, Inc. | Optimized dna cassettes for gene therapy |
| CN119736306B (zh) * | 2025-02-26 | 2025-09-12 | 上海奥浦迈生物科技股份有限公司 | 一种Noggin蛋白的表达载体及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109069668B (zh) * | 2015-12-14 | 2023-04-18 | 宾夕法尼亚州大学信托人 | 用于眼病的基因疗法 |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| US11827898B2 (en) * | 2017-06-14 | 2023-11-28 | The Trustees Of The University Of Pennsylvania | Gene therapy for ocular disorders |
| EP3775234A1 (en) * | 2018-04-05 | 2021-02-17 | NightstaRx Limited | Aav compositions, methods of making and methods of use |
-
2021
- 2021-08-31 CA CA3191545A patent/CA3191545A1/en active Pending
- 2021-08-31 WO PCT/US2021/048510 patent/WO2022051294A1/en not_active Ceased
- 2021-08-31 EP EP21864994.5A patent/EP4208182A4/en not_active Withdrawn
- 2021-08-31 CN CN202180073005.5A patent/CN116806158A/zh active Pending
- 2021-08-31 KR KR1020237006989A patent/KR102888699B1/ko active Active
- 2021-08-31 IL IL300752A patent/IL300752A/en unknown
- 2021-08-31 US US17/463,262 patent/US11357870B2/en active Active
- 2021-08-31 BR BR112023003840A patent/BR112023003840A2/pt unknown
- 2021-08-31 JP JP2023514413A patent/JP2023539367A/ja active Pending
- 2021-08-31 AU AU2021337580A patent/AU2021337580B2/en active Active
-
2022
- 2022-05-09 US US17/740,045 patent/US11524081B2/en active Active
- 2022-11-04 US US18/052,735 patent/US20230158172A1/en not_active Abandoned
-
2024
- 2024-07-09 US US18/766,963 patent/US20240358859A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023539368A5 (enExample) | ||
| AU2018200657B2 (en) | Methods of predicting ancestral virus sequences and uses thereof | |
| JP2021121638A5 (enExample) | ||
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP2022125201A (ja) | 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法 | |
| JP2023126919A5 (enExample) | ||
| JP2022530633A5 (enExample) | ||
| JP2024519888A5 (enExample) | ||
| JP2022544627A5 (enExample) | ||
| JP2022522776A5 (enExample) | ||
| JP2019537437A5 (enExample) | ||
| JP2019502378A5 (enExample) | ||
| JP2023503850A5 (enExample) | ||
| JP2023513004A5 (enExample) | ||
| WO2022222869A1 (zh) | 重组腺相关病毒及其应用 | |
| US20230220420A1 (en) | Gene therapy for bardet-biedl syndrome | |
| Chen | Adeno-associated virus vectors for human gene therapy | |
| JP2022523050A5 (enExample) | ||
| CN121693341A (zh) | 药物组合物及其用途 | |
| JP2024525742A5 (enExample) | ||
| HK40111900A (en) | Isolated modified aav9 capsid protein vp1 | |
| KR20260065692A (ko) | 아데노-관련 바이러스 변이체 및 그의 용도 | |
| HK40109360A (en) | Functional aav capsids for intravitreal administration | |
| HK40109737A (en) | Isolated modified aav5 capsid protein vp1 | |
| RU2021124726A (ru) | Выделенный модифицированный белок VPI капсида аденоассоциированного вируса 9 серотипа (AAV9), капсид и вектор на его основе |